Drugs / Nenocorilant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07276373 | Jan → Sep 2026 overdue | neoplasm | Corcept Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nenocorilant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07276373 ↗ |
| Known as | HY-147293 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4068844 ↗ |
| Modality | Small molecule | — CHEMBL4068844 ↗ |
| Route | Oral | “Nenocorilant will be administered orally once daily” NCT07276373 ↗ |